Latest News and Press Releases

SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...

Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...

EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB) In a non-clinical pharmacology study in an OAB model,...

SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...

Paris, France, 13 July, 2023 – EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, announces today the final closing of a Series A financing. EG 427 raised an...

MONROE, Conn., May 02, 2023 (GLOBE NEWSWIRE) -- Providing the same relief for overactive bladder (OAB) that they’ve become known for in the stress urinary incontinence arena, MedTech Elidah is...

Pune, April 04, 2023 (GLOBE NEWSWIRE) -- As per the report from SNS Insider, the Overactive Bladder Treatment Market was assessed at USD 3.63 billion in 2022 and is projected to expand to USD 4.89...

New York, USA, March 28, 2023 (GLOBE NEWSWIRE) -- Overactive Bladder Market to Grow Rapidly at a Considerable CAGR During the Forecast Period (2023–2032) | DelveInsight The overactive bladder...

Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Market Spotlight: Overactive Bladder" report has been added to ResearchAndMarkets.com's offering. Overactive bladder is characterized by urinary...

TAMPA, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life—from work performance to...